Toronto Memory Program

Memory Clinic specializing in #Alzheimer's disease & related dementias. Canada’s largest and most experienced site for #clinicaltrials in Alzheimer’s

[Toronto Memory Program @Toronto_Memory]

March is Amyloidosis Awareness Month!

Amyloidosis occurs when abnormal proteins (amyloid) build up in organs, affecting their function. In Cerebral Amyloid Angiopathy (CAA), amyloid deposits in brain blood vessels increase the risk of stroke, cognitive decline, and brain bleeds.

[Toronto Memory Program @Toronto_Memory]

Did you know that engaging in mentally stimulating activities, like solving Sudoku, can help build cognitive reserve? Cognitive reserve is the brain's ability to adapt and compensate for changes due to aging or neurological conditions.
https://t.co/78T6eBMB7s

[Toronto Memory Program @Toronto_Memory]

Boost your brainpower with the right foods! Research shows that a diet rich in leafy greens, fatty fish, berries, nuts, and even coffee or tea can support memory and cognitive function.

[Toronto Memory Program @Toronto_Memory]

A good night's sleep is essential for a healthy mind!

Did you know that sleep plays a crucial role in memory? It helps restructure and strengthen the brain, improving how we process and store information.

https://t.co/NmvMHtNRTA

[Toronto Memory Program @Toronto_Memory]

Happy New Year from Toronto Memory Program! Thank you to our community, patients, families, and staff for your continued support. We look forward to another year of advancing Alzheimer's disease research. Please note, we are closed on January 1.

[Natalia Kusendova-Bashta @NatKusendova]

Had a productive meeting this morning with @Toronto_Memory, which specializes in diagnosing and treating Alzheimer’s and dementia. We discussed the importance of providing tailored care to the majority of LTC residents who live with dementia.
(1/2)

[TNO-THE NEIGHBOURHOOD ORGANIZATION @TNOtoronto]

A huge thank you to @Toronto_Memory Program for their generous food drive donation and for volunteering with the Food Collaborative to help clients access essential food items!

[Toronto Memory Program @Toronto_Memory]

Toronto Memory Program will be closed on December 25 and 26. Wishing everyone a wonderful holiday season and all the best as the year comes to a close!

[Toronto Memory Program @Toronto_Memory]

Did you know? Alzheimer’s can begin 15-20 years before symptoms appear, in a silent phase called preclinical Alzheimer’s. During this time, amyloid plaques form in the brain, but memory remains normal.

[Toronto Memory Program @Toronto_Memory]

Curious about how to keep your brain healthy as you age? Cognitive reserve plays a key role in helping the brain adapt to challenges and ward off symptoms of diseases like Alzheimer's disease.
https://t.co/7IZ8NaawQ8

[Toronto Memory Program @Toronto_Memory]

The Bio-Hermes-002 research study seeks volunteers with or without memory concerns to help identify blood or digital tests that could help predict the presence of amyloid plaques or tau tangles in the brain, which are the hallmarks of Alzheimer’s disease.

https://t.co/ae5MVCvHQp

[Toronto Memory Program @Toronto_Memory]

The journey to understanding Alzheimer's began in the late 1890s with Auguste Deter, a woman whose memory loss intrigued Dr. Alois Alzheimer. His observations of her symptoms led to the identification of the brain changes associated with the disease.

https://t.co/D6UqqArJth

[Toronto Memory Program @Toronto_Memory]

As Ontario navigates the future of public access to new medicines, disease-modifying Alzheimer's treatments must be a priority. “This is an all-too-common disease affecting many Canadians,” says Dr. Sharon Cohen.

https://t.co/abEKTsJ7do

[Toronto Memory Program @Toronto_Memory]

September is World Alzheimer’s Month—a time to recognize the incredible commitment of our Alzheimer’s disease clinical research participants and their study partners. Your dedication to research participation plays a crucial role in advancing new treatments for Canadians.

[Toronto Memory Program @Toronto_Memory]

The Alzheimer's disease treatment landscape is rapidly changing, with several new FDA-approved antibody therapies that target amyloid plaque and aim to slow disease progression. Catch Dr. Sharon Cohen on this episode of Pharmacy Times!

https://t.co/Wh3Q2JZWzd

[Toronto Memory Program @Toronto_Memory]

We are pleased to announce that Great Britain has become the first country in Europe to grant authorization for lecanemab (Leqembi), a treatment for mild cognitive impairment and mild dementia due to Alzheimer's disease.

https://t.co/ilsBewq9OC

[Toronto Memory Program @Toronto_Memory]

Many factors can influence healthy aging. While some of these factors, such as genetics, are not within our control, research shows there are steps you can take to help manage your health as you age. Even making small changes in your daily life can help you live better.

[Toronto Memory Program @Toronto_Memory]

A blood test with 90% accuracy can now detect early signs of Alzheimer's disease, far outperforming traditional methods. At TMP, these groundbreaking tests are offered through research participation.

https://t.co/9FZv8kV1Yz

[Toronto Memory Program @Toronto_Memory]

Many factors may influence your risk of dementia, including genes, environment, and lifestyle. You can’t change some factors, but, as with many diseases, there may be steps you can take to help lower your risk.

[Toronto Memory Program @Toronto_Memory]

What should Canadians know about Donanemab (Kisunla)?

On July 2, 2024, the FDA granted full approval to Donanemab (Kisunla), a new drug that targets amyloid plaques in the brain to slow the progression of early-stage Alzheimer's disease.

https://t.co/eep1dhX3ZX